Cargando…
Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes
In this report we use ‘high-flux’ tributanoyl-modified N-acetylmannosamine (ManNAc) analogs with natural N-acetyl as well as non-natural azido- and alkyne N-acyl groups (specifically, 1,3,4-O-Bu(3)ManNAc, 1,3,4-O-Bu(3)ManNAz, and 1,3,4-O-Bu(3)ManNAl respectively) to probe intracellular sialic acid m...
Autores principales: | Saeui, Christopher T., Nairn, Alison V., Galizzi, Melina, Douville, Christopher, Gowda, Prateek, Park, Marian, Dharmarha, Vrinda, Shah, Sagar R., Clarke, Amelia, Austin, Melissa, Moremen, Kelley W., Yarema, Kevin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976204/ https://www.ncbi.nlm.nih.gov/pubmed/29847599 http://dx.doi.org/10.1371/journal.pone.0195812 |
Ejemplares similares
-
Cell Line-, Protein-, and Sialoglycosite-Specific Control of Flux-Based Sialylation in Human Breast Cells: Implications for Cancer Progression
por: Saeui, Christopher T., et al.
Publicado: (2020) -
Metabolic Glycoengineering Sensitizes Drug-Resistant Pancreatic Cancer Cells to Tyrosine Kinase Inhibitors Erlotinib and Gefitinib
por: Mathew, Mohit P., et al.
Publicado: (2015) -
Improving Immunotherapy Through Glycodesign
por: Buettner, Matthew J., et al.
Publicado: (2018) -
Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells
por: Mathew, Mohit P., et al.
Publicado: (2016) -
Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells
por: Tian, Yuan, et al.
Publicado: (2015)